22.27
price up icon5.20%   1.10
after-market アフターアワーズ: 22.27
loading
前日終値:
$21.17
開ける:
$21.29
24時間の取引高:
274.11K
Relative Volume:
0.72
時価総額:
$677.65M
収益:
$17.16M
当期純損益:
$-163.62M
株価収益率:
-4.2909
EPS:
-5.19
ネットキャッシュフロー:
$-121.61M
1週間 パフォーマンス:
+17.21%
1か月 パフォーマンス:
-36.64%
6か月 パフォーマンス:
-11.06%
1年 パフォーマンス:
+56.83%
1日の値動き範囲:
Value
$20.70
$22.38
1週間の範囲:
Value
$18.03
$22.38
52週間の値動き範囲:
Value
$13.36
$41.31

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1195)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
117
Name
Twitter
@anaptysbio
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

ANAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANAB 22.27 677.65M 17.16M -163.62M -121.61M -5.19
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
04:35 AM

Jennison Associates LLC Makes New Investment in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

04:35 AM
pulisher
Nov 22, 2024

Victory Capital Management Inc. Increases Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

AnaptysBio: An Immunology Pipeline-In-A-Pill Company Worth Watching - Seeking Alpha

Nov 21, 2024
pulisher
Nov 20, 2024

Down -32.84% in 4 Weeks, Here's Why You Should You Buy the Dip in AnaptysBio (ANAB) - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Truist maintains hold on AnaptysBio with $30 target By Investing.com - Investing.com UK

Nov 19, 2024
pulisher
Nov 17, 2024

AnaptysBio’s (ANAB) “Outperform” Rating Reiterated at Wedbush - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Analysts Set AnaptysBio, Inc. (NASDAQ:ANAB) Price Target at $54.64 - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher - Yahoo Finance

Nov 16, 2024
pulisher
Nov 12, 2024

JPMorgan Chase & Co. Issues Pessimistic Forecast for AnaptysBio (NASDAQ:ANAB) Stock Price - MarketBeat

Nov 12, 2024
pulisher
Nov 10, 2024

(ANAB) Proactive Strategies - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 09, 2024

Leerink Partnrs Lifts Earnings Estimates for AnaptysBio - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

What is Wedbush’s Forecast for AnaptysBio FY2024 Earnings? - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

FY2024 EPS Estimates for AnaptysBio Lifted by HC Wainwright - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

AnaptysBio (ANAB) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

What is Wedbush's Forecast for AnaptysBio FY2024 Earnings? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

HC Wainwright Has Lowered Expectations for AnaptysBio (NASDAQ:ANAB) Stock Price - Defense World

Nov 08, 2024
pulisher
Nov 08, 2024

AnaptysBio (NASDAQ:ANAB) Earns “Outperform” Rating from Wedbush - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

Lilly bid wilts as others forge on with PD-1 in RA - BioWorld Online

Nov 07, 2024
pulisher
Nov 07, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) May Have Run Too Fast Too Soon With Recent 33% Price Plummet - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

AnaptysBio Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

AnaptysBio (NASDAQ:ANAB) Shares Gap Up Following Strong Earnings - Defense World

Nov 07, 2024
pulisher
Nov 06, 2024

AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

AnaptysBio's (ANAB) Outperform Rating Reiterated at Wedbush - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

AnaptysBio (NASDAQ:ANAB) Shares Gap Up Following Earnings Beat - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

AnaptysBio shares hold Outperform rating; Leerink notes strong cash position and clinical progress - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

AnaptysBio stock target cut on increased expenses By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

AnaptysBio (ANAB) PT Lowered to $52 at H.C. Wainwright - StreetInsider.com

Nov 06, 2024
pulisher
Nov 06, 2024

AnaptysBio (ANAB) PT Lowered to $45 at Leerink Partners - StreetInsider.com

Nov 06, 2024
pulisher
Nov 06, 2024

AnaptysBio Inc (ANAB) Q3 2024 Earnings: Revenue Soars to $30M, E - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

AnaptysBio Reports Q3 2024 Financial Results and Updates - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

AnaptysBio, Inc. (ANAB) Tops Q3 EPS by 56c - StreetInsider.com

Nov 05, 2024
pulisher
Nov 05, 2024

Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Anaptys Announces Participation in November and December Investor Conferences - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

AnaptysBio's Q3 Revenue Surges to $30M, Cash Position Hits $458M Ahead of Key Trial Data | ANAB Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

AnaptysBio CEO to Present at 4 Major Healthcare Conferences Through Year-End | ANAB Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 04, 2024

AnaptysBio (NASDAQ:ANAB) Stock Price Down 5.4%Here's What Happened - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

Things To Consider Before Buying AnaptysBio Inc (NASDAQ: ANAB) - Stocks Register

Nov 02, 2024
pulisher
Nov 01, 2024

AnaptysBio: Too Risky, Especially After LLY Drops Its Related Programs - Seeking Alpha

Nov 01, 2024
pulisher
Oct 31, 2024

AnaptysBio (ANAB) Shares Plunge as Eli Lilly Ends Arthritis Drug Research - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

AnaptysBio (NASDAQ:ANAB) Given "Buy" Rating at HC Wainwright - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

(ANAB) Trading Advice - Stock Traders Daily

Oct 30, 2024
pulisher
Oct 30, 2024

AnaptysBio (NASDAQ:ANAB) Shares Gap DownHere's What Happened - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

AnaptysBio (NASDAQ:ANAB) PT Raised to $33.00 - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

AnaptysBio plunges as Eli Lilly drops co's arthritis drug from pipeline - XM

Oct 30, 2024
pulisher
Oct 30, 2024

AnaptysBio stock falls as Lilly updates pipeline (ANAB:NASDAQ) - Seeking Alpha

Oct 30, 2024
pulisher
Oct 30, 2024

O-I Glass Posts Downbeat Results, Joins AMD, Qorvo And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - TradingView

Oct 30, 2024
pulisher
Oct 27, 2024

Assenagon Asset Management S.A. Grows Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Oct 27, 2024
pulisher
Oct 25, 2024

AnaptysBio (NASDAQ:ANAB) Trading Down 6.9%Here's Why - MarketBeat

Oct 25, 2024
pulisher
Oct 23, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Receives $54.64 Consensus Price Target from Analysts - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

AnaptysBio (NASDAQ:ANAB) PT Raised to $90.00 - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

nVerses Capital LLC Buys 1,400 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Oct 22, 2024

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Anaptysbio Inc (ANAB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Lizzul Paul F.
Chief Medical Officer
Sep 23 '24
Sale
38.67
1,500
58,005
15,398
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):